MDCPartners founder and CEO, Mireille De Cré, explains how pharma R&D can make the most of the big data revolution.
The big data hype train has been gaining momentum for a number of years and its rise has been well documented. However, pharma companies are still perplexed by the scope of what big data can do, and why, how and where they should use big data tools to their advantage.